Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 October 2008, doi:10.1136/bmj.a2314
Cite this as: BMJ 2008;337:a2314
In this 10-minute Consultation article the authors, S W Mercer and M E J Lean, referred to the use of rimonabant (BMJ 2008;337; a1287, doi:10.1136/bmj.a1287). However, since the articles completion, the European Medicines Agency has announced that the drugs benefits no longer outweigh its risks and has suspended its marketing authorisation across the European Union (www.emea.europa.eu/humandocs/PDFs/EPAR/acomplia/53777708en.pdf).
Cite this as: BMJ 2008;337:a2314
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?